Trial Profile
A retrospective study of Tocilizumab in patients with polymyalgia rheumatica
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Prednisolone
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 22 Jul 2016 New trial record
- 11 Jun 2016 Results presented at the 17th Annual Congress of the European League Against Rheumatism